These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19253181

  • 1. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA, González I, Fernández FJ, Díaz S, Ferrer C, Alias E, Honrubia FM.
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [Abstract] [Full Text] [Related]

  • 2. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A, Borruat FX.
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [Abstract] [Full Text] [Related]

  • 3. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J, Pepper I, Hodgson T, Sharrack B.
    J Neuroophthalmol; 2011 Sep; 31(3):214-6. PubMed ID: 21566530
    [Abstract] [Full Text] [Related]

  • 4. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA, Levy SR.
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract] [Full Text] [Related]

  • 5. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL.
    Ophthalmic Plast Reconstr Surg; 2006 Feb; 22(1):53-5. PubMed ID: 16418668
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M, Gocmez E, Taskapili M.
    Bull Soc Belge Ophtalmol; 2009 Feb; (312):9-15. PubMed ID: 19927485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.
    Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E.
    Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM, Aouchiche R, Freedman KA.
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract] [Full Text] [Related]

  • 17. Possible effect of systemic sympathicolytic drugs on apraclonidine test.
    Martín-Moro JG, Botín DM, Muñoz-Negrete FJ.
    Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. But it's not all there.
    Peterson JD, Bilyk JR, Sergott RC.
    Surv Ophthalmol; 2013 Aug; 58(5):492-9. PubMed ID: 22784676
    [Abstract] [Full Text] [Related]

  • 20. Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?
    Kardon R.
    J Neuroophthalmol; 2005 Jun; 25(2):69-70. PubMed ID: 15937425
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.